Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Expert Rev Anti Infect Ther. 2015 Nov 4;:1-14
Authors: Goodman K, Simner P, Ta…
Prescribing patterns for upper respiratory tract infections: a prescription-review of primary care practice in Kedah, Malaysia, and the implications.
Expert Rev Anti Infect Ther. 2015 Sep 10;:1-10
Authors: Rezal RS, Hassali MA, Alrasheedy AA, Saleem F, Aryani Md Yusof F, Kamal M, Mohd Din R, Godman B
INTRODUCTION AND AIMS: It is necessary to ascertain current prescribing of antibiotics for upper respiratory tract infections (URTIs) to address potential overuse. A retrospective analysis was conducted of all prescriptions for URTIs among 10 public primary healthcare centers in Kedah, Malaysia, from 1 January to 31 March 2014.
RESULTS: A total of 123,524 prescriptions were screened and analyzed. Of these, 7129 prescriptions were for URTI, with 31.8% (n = 2269) containing antibiotics. Macrolides were the most commonly prescribed antibiotic, constituting 61% (n = 1403) of total antibiotics prescribed. There was a statistically significant association between different prescribers and diagnoses (p = 0.001) and a weak positive trend suggesting family medicine specialists are more competent in antibiotic prescribing, followed by medical officers and assistant medical officers (τ = 0.122).
CONCLUSIONS: Prescribing practices of some prescribers were inconsistent with current guidelines encouraging resistance development. National antimicrobial stewardship programs and further educational initiatives are ongoing in Malaysia to improve antibiotic use.
PMID: 26358203 [PubMed – as supplied by publisher]
Efficacy of telavancin, a lipoglycopeptide antibiotic, in experimental models of Gram-positive infection.
Expert Rev Anti Infect Ther. 2014 Dec;12(12):1463-75
Authors: Hegde SS, Janc JW
Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.
Expert Rev Anti Infect Ther. 2015 Jul;13(7):825-33
Authors: Nawar T, Kanafani ZA
Bacterial meningitis: an update of new treatment options.
Expert Rev Anti Infect Ther. 2015 Aug 21;:1-23
Authors: Nau R, Djukic M, Spreer A, Ribes S, Eiffert H
The outcome o…
Dalbavancin (BI-387) for the treatment of complicated skin and skin structure infection.
Expert Rev Anti Infect Ther. 2015 Feb;13(2):149-59
Authors: Leuthner KD, Yuen A, Mao Y, Rahbar A
Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.
Expert Rev Anti Infect Ther. 2015 Jul 12;:1-14
Authors: Henson KE, Levine MT, Wong EA, Levine DP
Oritavancin, a single-dose, complete regimen, for the treatment of acute bacterial skin and skin structure infections.
Expert Rev Anti Infect Ther. 2015 Apr;13(4):409-16
Authors: Wu G, Truong J, Lee…
Tedizolid for treatment of acute bacterial skin and skin structure infections.
Expert Rev Anti Infect Ther. 2015 Jul 27;:1-10
Authors: Hui Y, Xiaoju L
Tedizolid is a newly a…
Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis.
Expert Rev Anti Infect Ther. 2015 Jun 18;:1-13
Authors: Miyazaki T, Kohno S